Yong Guo - China National S Commission

600511 Stock   31.30  0.62  1.94%   

Executive

Yong Guo is S Commission of China National Medicines
Address Floor 6-9, West Tower, Beijing, China, 100077
Phone86 10 6727 1828
Webhttps://www.cncm.com.cn

China National Management Efficiency

The company has return on total asset (ROA) of 0.0436 % which means that it generated a profit of $0.0436 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.132 %, meaning that it generated $0.132 on every $100 dollars invested by stockholders. China National's management efficiency ratios could be used to measure how well China National manages its routine affairs as well as how well it operates its assets and liabilities. At present, China National's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 417.1 M, whereas Other Current Assets are forecasted to decline to about 9.5 M.

Similar Executives

Showing other executives

EXECUTIVE Age

Dongjie LiuShandong Publishing Media
61
Changchun WangShandong Publishing Media
58
Zhili XieTianjin Silvery Dragon
40
Jian ZouXinhua Winshare Publishing
52
Wei WeiShenyang Blue Silver
39
Dali ChenXinhua Winshare Publishing
62
Jian LiXinhua Winshare Publishing
60
Xuefeng ZhaoXinhua Winshare Publishing
60
Wei HuXinhua Winshare Publishing
52
Gui ZhengGuangdong Silvere Sci
47
Hongzhi GuiOffcn Education Technology
54
Xinhan WangOffcn Education Technology
52
Zhaoting XieTianjin Silvery Dragon
35
Xiaoping ZhangShenyang Blue Silver
44
Minghong HanShandong Publishing Media
55
Bo HuXinhua Winshare Publishing
51
Xuejun WangOffcn Education Technology
61
Bo FanShandong Publishing Media
43
Xiaofeng MaXinhua Winshare Publishing
52
Chun DaiBomesc Offshore Engineering
59
Hong LiuBomesc Offshore Engineering
53
China National Medicines (600511) is traded on Shanghai Stock Exchange in China and employs 3,138 people. China National is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

China National Medicines Leadership Team

Elected by the shareholders, the China National's board of directors comprises two types of representatives: China National inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China National's management team and ensure that shareholders' interests are well served. China National's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China National's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lichun Luo, Board Secretary
Guotao Tian, GM Director
Fei Chen, Chief Officer
Jie Wu, Deputy Mang
Xiaojuan Li, Financial Director
Pingxiao MBA, Financial Director
Wei Shao, Deputy Mang
Tong Ye, Deputy Mang
Yong Guo, S Commission
Zhang Ting, Deputy Committee

China Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China National a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

China National financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China National security.